NCT01892176View on ClinicalTrials.gov

Effects of High-dose Coenzyme Q10 on Biomarkers of Oxidative Damage and Clinical Outcome in Parkinson Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Parkinson Disease
Interventions
DIETARY_SUPPLEMENT

coenzyme q10

400mg/day, 800mg/day, 1200/day and 2400mg/day

Trial Locations (1)

119228

National University Health System, Singapore

All Listed Sponsors
lead

National University Hospital, Singapore

OTHER

NCT01892176 - Effects of High-dose Coenzyme Q10 on Biomarkers of Oxidative Damage and Clinical Outcome in Parkinson Disease | Biotech Hunter | Biotech Hunter